CH
CVI Holdings Portfolio holdings
AUM
$116M
This Quarter Return
+5.03%
1 Year Return
+3.84%
3 Year Return
+23.84%
5 Year Return
+272.82%
10 Year Return
–
AUM
$80.3M
AUM Growth
+$80.3M
(+9.6%)
Cap. Flow
+$8.29M
Cap. Flow
% of AUM
10.32%
Top 10 Holdings %
Top 10 Hldgs %
78.33%
Holding
71
New
24
Increased
2
Reduced
9
Closed
17
Top Buys
| 1 |
Novavax
NVAX
|
$4.44M |
| 2 |
Veritone
VERI
|
$4.4M |
| 3 |
NTBL
Notable Labs, Ltd. Ordinary Shares
NTBL
|
$4.17M |
| 4 |
TELL
Tellurian Inc.
TELL
|
$3.78M |
| 5 |
Astria Therapeutics
ATXS
|
$2.57M |
Top Sells
| 1 |
Agree Realty
ADC
|
$5.36M |
| 2 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$3.24M |
| 3 |
Akebia Therapeutics
AKBA
|
$3.12M |
| 4 |
MacroGenics
MGNX
|
$2.45M |
| 5 |
NVTA
Invitae Corporation
NVTA
|
$2.13M |
Sector Composition
| 1 | Healthcare | 26.86% |
| 2 | Communication Services | 15.54% |
| 3 | Energy | 6.49% |
| 4 | Technology | 5.56% |
| 5 | Consumer Staples | 2.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMWP
1
DELISTED
Eros Media World PLC
EMWP
| $12.5M | 15.54% | 960,238 +143,221 | +18% | +$1.86M |
|
|
2
Novavax
NVAX
$1.21B
| $4.44M | 5.53% | +3,315,597 | New | +$4.44M |
|
|
3
Veritone
VERI
$169M
| $4.4M | 5.47% | +261,422 | New | +$4.4M |
|
|
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $4.17M | 5.19% | +1,896,902 | New | +$4.17M |
|
|
TELL
5
DELISTED
Tellurian Inc.
TELL
| $3.78M | 4.71% | +454,294 | New | +$3.78M |
|
|
6
Astria Therapeutics
ATXS
$349M
| $2.57M | 3.2% | +2,680,752 | New | +$2.57M |
|
7
Marker Therapeutics
MRKR
$12M
| $2.36M | 2.94% | +250,000 | New | +$2.36M |
|
|
WHWK
8
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $1.87M | 2.33% | +450,676 | New | +$1.87M |
|
9
Kura Oncology
KURA
$686M
| $1.39M | 1.73% | +76,200 | New | +$1.39M |
|
|
NOVN
10
DELISTED
Novan, Inc. Common Stock
NOVN
| $1.19M | 1.48% | 405,131 -54,667 | -12% | -$161K |
|
|
FURY
11
Fury Gold Mines
FURY
$87.7M
| $1.07M | 1.33% | 978,630 -146,129 | -13% | -$159K |
|
12
Arcadia Biosciences
RKDA
$5.28M
| $984K | 1.22% | +119,333 | New | +$984K |
|
|
PFIE
13
DELISTED
Profire Energy, Inc
PFIE
| $939K | 1.17% | +277,721 | New | +$939K |
|
14
CEL-SCI Corp
CVM
$71.8M
| $737K | 0.92% | +801,006 | New | +$737K |
|
15
Nuwellis
NUWE
$4.6M
| $640K | 0.8% | +347,895 | New | +$640K |
|
16
Limoneira
LMNR
$285M
| $639K | 0.8% | +25,946 | New | +$639K |
|
17
Applied DNA Sciences
APDN
$1.69M
| $623K | 0.78% | 494,463 -83,678 | -14% | -$105K |
|
18
Recon Technology
RCON
$64.6M
| $493K | 0.61% | 354,572 -375,138 | -51% | -$522K |
|
|
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
| $480K | 0.6% | +45,057 | New | +$480K |
|
20
SEACOR Marine Holdings
SMHI
$173M
| $411K | 0.51% | +17,809 | New | +$411K |
|
21
SCYNEXIS
SCYX
$34.9M
| $388K | 0.48% | 236,531 -1,066,299 | -82% | -$1.75M |
|
|
FCSC
22
DELISTED
Fibrocell Science Inc.
FCSC
| $317K | 0.39% | +117,099 | New | +$317K |
|
|
NVIV
23
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $266K | 0.33% | +156,655 | New | +$266K |
|
24
Cardiff Oncology
CRDF
$140M
| $237K | 0.3% | +307,445 | New | +$237K |
|
25
Galmed Pharmaceuticals
GLMD
$6.96M
| $177K | 0.22% | +14,895 | New | +$177K |
|